Collegium Pharmaceutical COLL stock formed a Uptrend and downtrend channel patterns are technical analysis tools used to identify potential future price movements. They are formed by two parallel lines on a chart and can be u... breakout pattern on June 21, 2023. COLL stock has a weak downtrend technical rating.
Collegium Pharmaceutical is a pharmaceutical company that focuses on developing and commercializing innovative products for the treatment of chronic pain and other medical conditions. Their flagship product is Xtampza ER, an extended-release form of oxycodone that is designed to deter abuse and misuse. They also have other products in their pipeline for the treatment of pain and other conditions.